• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAF 富含半胱氨酸结构域:结构、功能及在疾病中的作用。

The RAF cysteine-rich domain: Structure, function, and role in disease.

机构信息

Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Hollings Cancer Center, Medical University of South Carolina.

出版信息

Adv Cancer Res. 2024;164:69-91. doi: 10.1016/bs.acr.2024.04.009. Epub 2024 May 14.

DOI:10.1016/bs.acr.2024.04.009
PMID:39306370
Abstract

RAF kinases, consisting of ARAF, BRAF and CRAF, are direct effectors of RAS GTPases and critical for signal transduction through the RAS-MAPK pathway. Driver mutations in BRAF are commonplace in human cancer, while germline mutations in BRAF and CRAF cause RASopathy development syndromes. However, there remains a lack of effective drugs that target RAF function, which is partially due to the complexity of the RAF activation cycle. Therefore, greater understanding of RAF regulation is required to identify new approaches that target its function in disease. A key piece of this puzzle is the RAF zinc finger, often referred to as the cysteine-rich domain (CRD). The CRD is a lipid and protein binding domain which plays complex and opposing roles in the RAF activation cycle. Firstly, it supports the RAS-RAF interaction during RAF activation by binding to phosphatidylserine (PS) in the plasma membrane and by making direct RAS contacts. Conversely, under quiescent conditions the CRD also plays a critical role in maintaining RAF in a closed, autoinhibited state. However, the interplay between these activities and their relative importance for RAF activation were not well understood. Recent structural and biochemical studies have contributed greatly to our understanding of these roles and identified functional differences between BRAF CRD and that of CRAF. This chapter provides an in-depth review of the CRDs roles in RAF regulation and how they may inform novel approaches to target RAF function.

摘要

RAF 激酶,包括 ARAF、BRAF 和 CRAF,是 RAS GTPases 的直接效应物,对于通过 RAS-MAPK 途径进行信号转导至关重要。BRAF 中的驱动突变在人类癌症中很常见,而 BRAF 和 CRAF 的种系突变会导致 RAS 病发展综合征。然而,目前仍然缺乏针对 RAF 功能的有效药物,部分原因是 RAF 激活循环的复杂性。因此,需要更好地了解 RAF 调节机制,以确定针对其在疾病中功能的新方法。这一难题的关键部分是 RAF 锌指,通常称为富含半胱氨酸的结构域(CRD)。CRD 是一个脂质和蛋白质结合域,在 RAF 激活循环中发挥着复杂且相反的作用。首先,它通过与质膜中的磷脂酰丝氨酸(PS)结合以及与 RAS 直接接触,在 RAF 激活过程中支持 RAS-RAF 相互作用。相反,在静止状态下,CRD 也在维持 RAF 处于封闭的、自动抑制状态中发挥着关键作用。然而,这些活性之间的相互作用及其对 RAF 激活的相对重要性尚未得到很好的理解。最近的结构和生化研究极大地促进了我们对这些作用的理解,并确定了 BRAF CRD 与 CRAF 的 CRD 之间的功能差异。本章深入探讨了 CRD 在 RAF 调节中的作用,以及它们如何为靶向 RAF 功能的新方法提供信息。

相似文献

1
The RAF cysteine-rich domain: Structure, function, and role in disease.RAF 富含半胱氨酸结构域:结构、功能及在疾病中的作用。
Adv Cancer Res. 2024;164:69-91. doi: 10.1016/bs.acr.2024.04.009. Epub 2024 May 14.
2
RASopathy mutations provide functional insight into the BRAF cysteine-rich domain and reveal the importance of autoinhibition in BRAF regulation.RASopathy 突变提供了 BRAF 半胱氨酸丰富结构域的功能见解,并揭示了 BRAF 调节中自身抑制的重要性。
Mol Cell. 2022 Nov 17;82(22):4262-4276.e5. doi: 10.1016/j.molcel.2022.10.016. Epub 2022 Nov 7.
3
Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.KRAS 与 CRAF 的 RAS 结合域和富含半胱氨酸域在膜上的多价组装。
Proc Natl Acad Sci U S A. 2020 Jun 2;117(22):12101-12108. doi: 10.1073/pnas.1914076117. Epub 2020 May 15.
4
Regulation of RAF family kinases: new insights from recent structural and biochemical studies.RAF 家族激酶的调控:来自近期结构和生化研究的新见解。
Biochem Soc Trans. 2024 Jun 26;52(3):1061-1069. doi: 10.1042/BST20230552.
5
Crystal Structure Reveals the Full Ras-Raf Interface and Advances Mechanistic Understanding of Raf Activation.晶体结构揭示了完整的 Ras-Raf 界面,并深入了解了 Raf 激活的机制。
Biomolecules. 2021 Jul 7;11(7):996. doi: 10.3390/biom11070996.
6
ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers.ARAF 作为支架稳定 BRAF:CRAF 异二聚体。
Oncogene. 2013 Jun 27;32(26):3207-12. doi: 10.1038/onc.2012.330. Epub 2012 Aug 27.
7
Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain.膜上 RAS/RAF 复合物的分子识别:RAF 富含半胱氨酸结构域的作用。
Sci Rep. 2018 May 31;8(1):8461. doi: 10.1038/s41598-018-26832-4.
8
LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors.LXH254,一种强效和选择性的 ARAF spared BRAF 和 CRAF 抑制剂,用于治疗 MAPK 驱动的肿瘤。
Clin Cancer Res. 2021 Apr 1;27(7):2061-2073. doi: 10.1158/1078-0432.CCR-20-2563. Epub 2020 Dec 22.
9
The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway.中间活性(L597V)BRAF 突变体通过增强 RAF/MEK/ERK 通路的信号转导,作为致癌 RAS 的上位修饰因子而起作用。
Genes Dev. 2012 Sep 1;26(17):1945-58. doi: 10.1101/gad.193458.112. Epub 2012 Aug 14.
10
The strength of interaction at the Raf cysteine-rich domain is a critical determinant of response of Raf to Ras family small GTPases.Raf富含半胱氨酸结构域处的相互作用强度是Raf对Ras家族小GTP酶反应的关键决定因素。
Mol Cell Biol. 1999 Sep;19(9):6057-64. doi: 10.1128/MCB.19.9.6057.

引用本文的文献

1
Ensemble-Based Binding Free Energy Profiling and Network Analysis of the KRAS Interactions with DARPin Proteins Targeting Distinct Binding Sites: Revealing Molecular Determinants and Universal Architecture of Regulatory Hotspots and Allosteric Binding.基于集成的KRAS与靶向不同结合位点的DARPin蛋白相互作用的结合自由能分析及网络分析:揭示调控热点和变构结合的分子决定因素及通用结构
Biomolecules. 2025 Jun 5;15(6):819. doi: 10.3390/biom15060819.
2
B-AP15 inhibited colon cancer cell proliferation by decreasing CDK6, Cyclin A, Cyclin E, c-Myc, and VEGF gene expression.B-AP15通过降低CDK6、细胞周期蛋白A、细胞周期蛋白E、c-Myc和VEGF基因的表达来抑制结肠癌细胞增殖。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 29. doi: 10.1007/s00210-025-03940-3.